Depomed To Acquire Rights To NUCYNTA Franchise For $1.05 Billion By: Benzinga via Benzinga January 15, 2015 at 17:23 PM EST Depomed Inc (NASDAQ: DEPO) announced Thursday that it will acquire the U.S. rights to the NUCYNTA franchise from Johnson & ... Read More >> Related Stocks: Depomed Inc Johnson & Johnson Macy's